«The signals that come from the European and the Middle East markets are positive: our partners – says Lucio Zaghetto, CEO of ASAlaser, summing up the participation of the company to Medica 2014 - in fact foresee a growth for 2015, year that will launch us towards new goals. Remarkable is also the attention given to us by Asian countries, which have attended Medica unlike Latin American countries that traditionally attend other fairs. No secondary, finally, is the start-up of the Indonesian market, and the interest shown by Thailand in our dental sector. A good reason to take part in the TDA 2014 fair in Bangkok from the 17th to the 19th of December». For the 31st consecutive year Medica (Düsseldorf, 12/15 November) has been confirmed to be a good opportunity for ASAlaser to feel the pulse of international markets and to meet loyal customers and new partners from the four corners of the world that meet here for an overview of the latest news. «The dental field - confirms Giacomo Granozio, Asalaser’s Area Manager - has attracted the interest of Asian companies. Soon we will begin to reap the first fruits even in Australia where it has been launched in mid-year. We confirm, therefore, the good potential of this line in Southeast Asia and Oceania». And Europe? Encouraging feedbacks came also from the Old Continent. «In general there is an attitude of confidence among European partners - says Roberto Terruzzi, ASAlaser’s Area Manager - who strongly believe in the recovery for 2015 even from critical markets such as Greece». If Asia and Europe confirm their push to make a significant change next year, America for ASAlaser remains a primary partner. «For the first time - comments Roberto Marchesini, ASAlaser’s Managing Director - we had a visit from Cutting Edge Laser Technologies, our US distributor. Its referent Mark Mollenkopf has been amazed by the extent of the fair in terms of exhibitors and number of visitors, confirming that in the US there is no such event. That is why we consider essential to participate and to bring something new every year. 2014 has been characterized by the new corporate identity represented by a photograph that sums up the two souls of the company, Human and Vet, gathering up all our referents: doctors and veterinarians, patients and animals». A choice that has garnered enthusiastic feedbacks from distributors and visitors of the stand, completely revised in its design considering the diktat of the new communication campaign. «Popular between professionals who have visited us - says Roberta Zuffellato from ASAlaser’s Sales Department - has been also the video "Mimic the pain", broadcast by the TV stand: some students present at Medica after seeing it have simulated a personal "mimic”». ASAlaser confirms its trailblazer role in this field, as well as in laser therapy where, for over 30 years, brings innovation through research and technology. «At Medica’s international showcase - says Silvia Vitulo, ASAlaser’s Product Specialist - our company confirms its leadership in the field of laser therapy, for the uniqueness of its therapeutic solutions, for the high scientific and technologic content resulting from basic and clinical research, for the completeness of the range of products offered, able to satisfy every need, and for the attention to design, ergonomics and usability details that characterizes each product».
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.